Clinical Trial Update: Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT [Phase 2, Phase 3]

View source ↗

Summary

A randomized, placebo-controlled Phase 2/3 trial evaluating intralymphatic immunotherapy enhanced by Vitamin D for grass pollen-induced allergic rhinitis, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Intralymphatic immunotherapy enhanced by Vitamin-D
• Sublingual immunotherapy (SLIT) (Sublingual immunotherapy)

Snippet

Sponsor: Lars Olaf Cardell | Conditions: Allergic Rhinitis Due to Grass Pollen | Phase 2, Phase 3 | Status: RECRUITING